News

Fierce Biotech27m
Eli Lilly pens Creyon Bio AI oligonucleotide pact with $1B in biobucks on the table
Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed ...
Fierce Biotech40m
FDA misses PDUFA date for Stealth’s ultra-rare disease candidate, delaying approval decision—again
An approval decision for Stealth BioTherapeutics’ investigational treatment for an ultra-rare genetic disease has been ...